PRQR
ProQR Therapeutics BVNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$189.65M
P/E Ratio
—
EPS
$-0.47
Beta
0.09
52W High
$3.10
52W Low
$1.10
50-Day MA
$1.61
200-Day MA
$2.05
Dividend Yield
—
Profit Margin
-258.00%
Forward P/E
—
PEG Ratio
0.00
About ProQR Therapeutics BV
ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.
Fundamentals
| Revenue (TTM) | $16.35M |
| Gross Profit (TTM) | $16.35M |
| EBITDA | $-42.54M |
| Operating Margin | -192.90% |
| Return on Equity | -61.20% |
| Return on Assets | -19.40% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $0.55 |
| Price-to-Book | 3.28 |
| Price-to-Sales (TTM) | 11.60 |
| EV/Revenue | 5.36 |
| EV/EBITDA | -2.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.10% |
| Shares Outstanding | $105.36M |
| Float | $64.07M |
| % Insiders | 17.66% |
| % Institutions | 50.80% |
Historical Volatility
HV 10-Day
97.63%
HV 20-Day
94.00%
HV 30-Day
92.77%
HV 60-Day
73.48%
HV Rank
91.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.88 target)
1
Strong Buy7
BuyData last updated: 4/14/2026